Illumina (ILMN) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Illumina Revenue Highlights

Latest Revenue (Y)

$4.50B

Latest Revenue (Q)

$1.08B

Main Segment (Y)

Core Illumina

Main Geography (Y)

Americas

Illumina Revenue by Period

Illumina Revenue by Year

Date	Revenue	Change
2023-12-31	$4.50B	-1.75%
2023-01-01	$4.58B	1.28%
2022-01-02	$4.53B	39.73%
2021-01-03	$3.24B	-8.58%
2019-12-29	$3.54B	6.30%
2018-12-30	$3.33B	21.11%
2017-12-31	$2.75B	14.74%
2017-01-01	$2.40B	8.05%
2016-01-03	$2.22B	19.25%
2014-12-28	$1.86B	30.97%
2013-12-29	$1.42B	23.74%
2012-12-30	$1.15B	8.81%
2012-01-01	$1.06B	16.93%
2011-01-02	$902.74M	35.48%
2010-01-03	$666.32M	16.24%
2008-12-28	$573.23M	56.28%
2007-12-30	$366.80M	98.71%
2006-12-31	$184.59M	151.13%
2006-01-01	$73.50M	45.31%
2005-01-02	$50.58M	80.43%
2003-12-28	$28.04M	179.23%
2002-12-29	$10.04M	303.86%
2001-12-30	$2.49M	89.90%
2000-12-31	$1.31M	176.17%
1999-12-31	$474.03K	-

Illumina generated $4.50B in revenue during NA 2023, up -1.75% compared to the previous quarter, and up 135.13% compared to the same period a year ago.

Illumina Revenue by Quarter

Date	Revenue	Change
2024-09-29	$1.08B	-2.88%
2024-06-30	$1.11B	3.35%
2024-03-31	$1.08B	-4.10%
2023-12-31	$1.12B	0.27%
2023-10-01	$1.12B	-4.85%
2023-07-02	$1.18B	8.19%
2023-04-02	$1.09B	0.37%
2023-01-01	$1.08B	-2.87%
2022-10-02	$1.11B	-4.04%
2022-07-03	$1.16B	-4.99%
2022-04-03	$1.22B	2.09%
2022-01-02	$1.20B	8.12%
2021-10-03	$1.11B	-1.60%
2021-07-04	$1.13B	3.02%
2021-04-04	$1.09B	14.69%
2021-01-03	$953.00M	20.03%
2020-09-27	$794.00M	25.43%
2020-06-28	$633.00M	-26.31%
2020-03-29	$859.00M	-9.86%
2019-12-29	$953.00M	5.07%
2019-09-29	$907.00M	8.23%
2019-06-30	$838.00M	-0.95%
2019-03-31	$846.00M	-2.42%
2018-12-30	$867.00M	1.64%
2018-09-30	$853.00M	2.77%
2018-07-01	$830.00M	6.14%
2018-04-01	$782.00M	0.51%
2017-12-31	$778.00M	8.96%
2017-10-01	$714.00M	7.85%
2017-07-02	$662.00M	10.70%
2017-04-02	$598.00M	-3.45%
2017-01-01	$619.35M	2.01%
2016-10-02	$607.14M	1.17%
2016-07-03	$600.12M	4.96%
2016-04-03	$571.76M	-3.34%
2016-01-03	$591.55M	7.50%
2015-09-27	$550.27M	2.02%
2015-06-28	$539.38M	0.15%
2015-03-29	$538.57M	5.11%
2014-12-28	$512.38M	6.61%
2014-09-28	$480.63M	7.39%
2014-06-29	$447.57M	6.37%
2014-03-30	$420.78M	8.64%
2013-12-29	$387.33M	8.56%
2013-09-29	$356.80M	3.09%
2013-06-30	$346.09M	4.57%
2013-03-31	$330.96M	7.01%
2012-12-30	$309.26M	8.18%
2012-09-30	$285.87M	1.88%
2012-07-01	$280.61M	2.87%
2012-04-01	$272.77M	9.08%
2012-01-01	$250.07M	6.19%
2011-10-02	$235.50M	-18.07%
2011-07-03	$287.45M	1.75%
2011-04-03	$282.51M	8.12%
2011-01-02	$261.30M	10.11%
2010-10-03	$237.31M	11.94%
2010-07-04	$212.00M	10.34%
2010-04-04	$192.13M	6.41%
2010-01-03	$180.56M	14.02%
2009-09-27	$158.36M	-2.03%
2009-06-28	$161.64M	-2.48%
2009-03-29	$165.76M	3.00%
2008-12-28	$160.93M	7.10%
2008-09-28	$150.26M	7.19%
2008-06-29	$140.18M	15.03%
2008-03-30	$121.86M	-

Illumina generated $1.08B in revenue during Q3 2024, up -2.88% compared to the previous quarter, and up 91.84% compared to the same period a year ago.

Illumina Revenue Breakdown

Illumina Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Jan 23	Jan 22	Jan 21	Dec 19
GRAIL, Inc.	$93.00M	$55.00M	$12.00M	-	-
Core Illumina	$4.44B	$4.55B	$4.52B	-	-
Consolidated Variable Interest Entities	-	-	-	-	-
Service, Other	-	-	-	$220.00M	$240.00M
Product	-	-	-	$788.00M	$802.00M

Illumina's latest annual revenue breakdown by segment (product or service), as of Dec 23: Core Illumina (97.95%), and GRAIL, Inc. (2.05%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
Microarray	$85.00M	$97.00M	$105.00M	$93.00M	$105.00M	$114.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sequencing	$995.00M	$979.00M	$1.09B	$1.01B	$1.02B	$979.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Service	-	$200.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product	-	$876.00M	$831.00M	$812.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Consumables	-	$762.00M	$686.00M	$665.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Instruments	-	$114.00M	$145.00M	$147.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Core Illumina	-	-	$2.20B	$1.16B	$1.08B	$1.07B	$1.11B	$1.16B	$1.22B	-	-	-	-	-	-	-	-	-	-	-
GRAIL, Inc.	-	-	$51.00M	$22.00M	$20.00M	$23.00M	$10.00M	$12.00M	$10.00M	-	-	-	-	-	-	-	-	-	-	-
Service, Other	-	-	-	-	-	-	-	-	-	-	-	-	-	$122.00M	$118.00M	$106.00M	$158.00M	$140.00M	$161.00M	$134.00M

Illumina's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Sequencing (92.13%), and Microarray (7.87%).

Illumina Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Jan 23	Jan 22	Jan 21	Dec 19
UNITED STATES	$2.36B	$2.29B	$2.19B	$1.66B	$1.86B
Americas	$2.52B	$2.48B	$2.36B	$1.74B	$1.97B
CHINA	$384.00M	$472.00M	$502.00M	$342.00M	$372.00M
Europe	$1.14B	-	-	-	-
Asia Pacific	-	$418.00M	$377.00M	$267.00M	$268.00M
EMEA	-	$1.22B	$1.29B	$886.00M	$933.00M

Illumina's latest annual revenue breakdown by geography, as of Dec 23: Americas (39.37%), UNITED STATES (36.84%), Europe (17.80%), and CHINA (6.00%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Dec 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
EMEA	$291.00M	$279.00M	$301.00M	$290.00M	$308.00M	$316.00M	$351.00M	$313.00M	$320.00M	$305.00M	$284.00M	$213.00M	$168.00M	$221.00M	$280.00M	$235.00M	-	-	-	-
Americas	$609.00M	$603.00M	$1.26B	$640.00M	$616.00M	$594.00M	$597.00M	$639.00M	$648.00M	$625.00M	$583.00M	$589.00M	$562.00M	$496.00M	$436.00M	$335.00M	$477.00M	$507.00M	$514.00M	$476.00M
CHINA	$75.00M	$78.00M	$178.00M	$115.00M	$91.00M	$94.00M	$133.00M	$118.00M	$127.00M	$120.00M	$122.00M	$132.00M	$127.00M	$96.00M	$83.00M	$79.00M	$84.00M	$92.00M	$95.00M	$97.00M
Europe	-	$279.00M	$576.00M	$303.00M	$261.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Asia Pacific	-	-	-	-	-	$94.00M	$95.00M	$97.00M	$132.00M	$103.00M	$90.00M	$85.00M	$99.00M	$77.00M	$62.00M	$51.00M	$77.00M	$73.00M	$63.00M	$57.00M
Europe, Middle East, And Africa	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$208.00M

Illumina's latest quarterly revenue breakdown by geography, as of Sep 24: Americas (62.46%), EMEA (29.85%), and CHINA (7.69%).

Illumina Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
TMO	Thermo Fisher Scientific	$42.86B	$10.60B
DHR	Danaher	$14.03B	$3.40B
A	Agilent	$6.83B	$1.58B
ILMN	Illumina	$4.50B	$1.08B
IDXX	IDEXX Laboratories	$3.66B	$975.54M
WAT	Waters	$2.96B	$740.30M
EXAS	Exact Sciences	$2.50B	$708.65M
NTRA	Natera	$1.08B	$439.76M
CDNA	CareDx	$280.32M	$82.88M
TWST	Twist Bioscience	$245.11M	$81.46M

ILMN Revenue FAQ

What is Illumina’s yearly revenue?

Illumina's yearly revenue for 2023 was $4.5B, representing a decrease of -1.75% compared to 2022. The company's yearly revenue for 2022 was $4.58B, representing an increase of 1.28% compared to 2021. ILMN's yearly revenue for 2021 was $4.53B, representing an increase of 39.73% compared to 2020.

What is Illumina’s quarterly revenue?

Illumina's quarterly revenue for Q3 2024 was $1.08B, a -2.88% decrease from the previous quarter (Q2 2024), and a -3.49% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $1.11B, a 3.35% increase from the previous quarter (Q1 2024), and a -5.44% decrease year-over-year (Q2 2023). ILMN's quarterly revenue for Q1 2024 was $1.08B, a -4.10% decrease from the previous quarter (Q4 2023), and a -1.01% decrease year-over-year (Q1 2023).

What is Illumina’s revenue growth rate?

Illumina's revenue growth rate for the last 3 years (2021-2023) was -0.49%, and for the last 5 years (2019-2023) was 27.12%.

What are Illumina’s revenue streams?

Illumina's revenue streams in c 23 are GRAIL, Inc., and Core Illumina. GRAIL, Inc. generated $93M in revenue, accounting 2.05% of the company's total revenue, up 69.09% year-over-year. Core Illumina generated $4.44B in revenue, accounting 97.95% of the company's total revenue, down -2.53% year-over-year.

What is Illumina’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Illumina was Core Illumina. This segment made a revenue of $4.44B, representing 97.95% of the company's total revenue.